Series 1 · Active
The Quiet Dismantling
A six-week investigation. Signal · Briefing · Viva Voce, every week.
The Labora Collective publishes argument-first, against a permanent spine of numbered Doctrine theses about how women's and children's health is being engineered in the United States.
Each thesis runs six weeks, and every week tells the same story three ways — the new evidence, the structural mechanics, and the human translation:
Below is the active thesis, the six-week arc, and what's running on the Collective this week.
One thesis, one new data point — short, direct, declarative. What changed, and why it matters now.
How it works, why it’s legal, and who built it. The procedural machinery underneath the headline.
What the issue does to a body — and what it looks like inside the exam room. Doctor to community, in plain voice.
How the federal safety net for women's and children's healthcare is being dissolved administratively — without a Congressional vote.
Title X. PRAMS. Medication shortages. The pharmacy backstop. Medicaid. The clinical workforce. Six weeks. Six pieces of infrastructure being hollowed out, one by one, by mechanisms that do not require legislation. We trace the new evidence, the structural mechanics, and what it looks like inside an exam room when the safety net is gone.
A workforce that depends on women returning to work
Housing is healthcare. A stable, secure place to live is a prerequisite for a healthy pregnancy — and this patient's most dangerous exposure never made it onto the monitor.
The ACA made maternity and newborn care an essential benefit every marketplace plan had to cover, and barred insurers from turning women away. This is the patient who did everything right — and the morning the subsidies expired.
Kicking away the ladder: the deliberate unmaking of the Black middle class — and why maternal death is the canary
A maternal health system does not run on funding and buildings. It runs on specialists — and legal risk and criminalization are driving them out of ban states faster than anyone is replacing them.
Medicaid pays for roughly forty percent of all births in this country. Nobody is repealing it — procedural unenrollment is hollowing it out one renewal form at a time.
The retail pharmacy is the last node in the reproductive healthcare system — the one standing between a valid prescription and the medication in your hand. The chains are becoming the new gatekeepers.
Obstetric drug shortages are creating life-threatening gaps in hemorrhage and seizure protocols. Oxytocin, misoprostol, magnesium sulfate—cheap generics that prevent maternal death—are vanishing from hospital code carts while regulators track national output, not bedside reality.
The CDC PRAMS team has been on administrative leave for thirteen months; the 2023 dataset was finished and never released; the state grants expired April 30. Action through omission — the same playbook as Title X, applied to America’s only maternal-experience surveillance system.
Title X — the only federal family-planning program — is being dissolved without a repeal vote: the administering office cut from ~50 staff to one, the FY2027 mission rewritten from contraception to "fertility awareness," and funding routed toward Crisis Pregnancy Centers. A clinical case opens the pattern; the House markup on June 5 is the next inflection point.